US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 5.460
- +0.060+1.11%
Close Nov 13 16:00 ET
- 5.390
- -0.070-1.28%
Post 20:01 ET
318.36MMarket Cap-18827P/E (TTM)
5.525High5.370Low747.84KVolume5.470Open5.400Pre Close4.09MTurnover1.42%Turnover Ratio136.50P/E (Static)58.31MShares6.75052wk High0.59P/B286.82MFloat Cap3.44052wk Low--Dividend TTM52.53MShs Float33.440Historical High--Div YieldTTM2.87%Amplitude0.450Historical Low5.465Avg Price1Lot Size
Vanda Pharmaceuticals News
H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $18
Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $13
Vanda Pharma Analyst Ratings
H.C. Wainwright Initiates Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18
Cantor Fitzgerald Maintains Overweight on Vanda Pharma, Raises Price Target to $13
Vanda Pharma Analyst Ratings
Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Raises Target Price to $13
Vanda Pharma Analyst Ratings
Cantor Fitzgerald Initiates Coverage On Vanda Pharma With Overweight Rating, Announces Price Target of $11
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data